valine has been researched along with Alloxan Diabetes in 78 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (15.38) | 18.7374 |
| 1990's | 8 (10.26) | 18.2507 |
| 2000's | 32 (41.03) | 29.6817 |
| 2010's | 25 (32.05) | 24.3611 |
| 2020's | 1 (1.28) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez, C; Álvarez-Cilleros, D; Amigó, N; Chagoyen, M; Correig, X; Fernández-Millán, E; Martín, MÁ; Ramos, S; Samino, S | 1 |
| Li, Y; Liu, X; Patel, KP; Zheng, H | 1 |
| Shibata, K | 1 |
| Cong, XD; Dai, DZ; Dai, Y; Shi, FH; Wu, Y; Zhang, YM | 1 |
| Cong, XD; Dai, DZ; Dai, Y; Ding, MJ; Liu, GL; Zhang, YM | 1 |
| El-Maraghy, SA; Motawi, TK; Senousy, MA | 1 |
| Wei, JR; Zhang, YL | 1 |
| Guan, G; Li, P; Lv, W; Qi, D; Wang, J; Zhang, Y | 1 |
| Araki, E; Goto, R; Igata, M; Kawasaki, S; Kawashima, J; Kitano, S; Kondo, T; Matsumura, T; Matsuyama, R; Miyagawa, K; Motoshima, H; Ono, K | 1 |
| Cheung, AK; Huang, Y; Liu, X; Zhou, G | 1 |
| Baker, KM; Chandel, N; Kumar, R; Seqqat, R; Thomas, CM; Yong, QC | 1 |
| Howard, A; Kopp, JB; Levi, M; Li, C; Qiu, L; Solis, N; Wang, W; Wang, X | 1 |
| Chang, KC; Ha, YM; Kang, YJ; Kim, HJ; Park, EJ; Park, SW | 1 |
| Bisht, S; De, A; Ram, V; Singh, MF; Singh, V | 1 |
| Chen, ZJ; Fu, P; Huang, SM; Tang, WX; Tao, Y | 1 |
| Chen, B; Guan, GJ; Hou, XH; Li, XG; Liu, G; Liu, JL; Zhang, Y | 1 |
| Abadir, PM; Abdel-Rahman, EM; Siragy, HM | 1 |
| Lu, J; Sun, L; Yu, XJ; Zang, WJ; Zhang, CH | 1 |
| Chen, FM; Fu, GS; Wang, H; Wang, YJ | 1 |
| Cheng, S; Li, H; Li, J; Li, X; Qi, C; Xu, G; Yuan, L | 1 |
| Li, X; Qi, CJ; Xu, GL; Yuan, L | 1 |
| Kamal, F; Morioka, T; Oite, T; Piao, H; Yanakieva-Georgieva, N | 1 |
| Huang, J; Matavelli, LC; Siragy, HM | 1 |
| Dong, Z; Ge, Z; Geng, J; Kang, W; Liu, G; Sun, Y; Wu, T; Zhang, Y | 1 |
| Birnbaum, Y; Castillo, AC; Perez-Polo, JR; Qian, J; Ye, Y | 1 |
| Chen, H; Li, H; Liu, Z; Tang, L; Yang, B; Yi, R | 1 |
| Fan, J; Hoffman, MR; Qin, Y; Ren, H; Xu, G; Zhang, M | 1 |
| Chen, B; Du, G; Guo, J; Li, X; Qiang, G; Shi, L; Xuan, Q; Yang, H; Yang, X; Zhang, H; Zhang, L; Zhou, D; Zu, M | 1 |
| Aksak, S; Albayrak, A; Albayrak, F; Gundogdu, C; Halici, Z; Karakus, E; Kiki, I; Ozturk, B; Polat, B; Sipal, S | 1 |
| Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T | 1 |
| Oka, JI; Sacai, H; Sasaki-Hamada, S | 1 |
| Baker, KM; Chandel, N; Feldman, DL; Kumar, R; Seqqat, R; Thomas, CM; Yong, QC | 1 |
| Allen, TJ; Cao, Z; Cooper, ME; Davis, BJ; de Gasparo, M; Kawachi, H | 1 |
| Allen, TJ; Burrell, LM; Cao, Z; Cooper, ME; Davis, BJ; Lassila, M | 1 |
| Chan, P; Cheng, JT; Liu, IM; Tzeng, TF; Wong, KL; Yang, TL | 1 |
| Abadir, P; Awad, A; Siragy, HM; Webb, R | 1 |
| Awad, AS; Carey, RM; Siragy, HM; Webb, RL | 2 |
| Alderson, NL; Cooper, ME; Forbes, JM; Thomas, MC; Thorpe, SR | 1 |
| Xie, XW; Zhao, P | 1 |
| Chu, GL; Ding, GH; Gao, P; Jia, RH; Liu, HY; Song, EF; Yang, DP | 1 |
| Siragy, HM; Xue, C | 1 |
| Ma, X; Miao, Y; Sun, H; Tang, MX; Zhang, W; Zhang, Y; Zhong, M | 1 |
| Gong, HP; Li, L; Ma, X; Miao, Y; Sun, H; Zhang, W; Zhang, Y; Zhong, M | 1 |
| Chan, P; Cheng, JT; Liu, IM; Tzeng, TF; Yang, TL | 1 |
| Fletcher, EL; Phipps, JA; Wilkinson-Berka, JL | 1 |
| Jaworski, K; Ninkovic, S; Tan, G; Wilkinson-Berka, JL | 1 |
| Ma, X; Miao, Y; Qi, TG; Sun, H; Zhang, W; Zhong, M | 1 |
| Inoue, M; Ishida, S; Izumi-Nagai, K; Koto, T; Nagai, N; Oike, Y; Ozawa, Y; Satofuka, S; Tsubota, K; Umezawa, K; Yamashiro, K | 1 |
| Bai, A; Bianchi, R; Cuccovillo, I; De Angelis, N; Fiordaliso, F; Latini, R; Masson, S; Razzetti, R; Salio, M; Serra, DM | 1 |
| Huang, J; Siragy, HM | 1 |
| Imamura, Y; Ishida, S; Kurihara, T; Nagai, N; Noda, K; Oike, Y; Okano, H; Ozawa, Y; Shinoda, K; Tsubota, K | 1 |
| Ben Abdeljlil, A; Desnuelle, P; Palla, JC | 2 |
| Crandall, EA; Fernstrom, JD | 1 |
| Hagihira, H; Ishikawa, Y; Misake, A; Nakabou, Y | 1 |
| Harper, AE; Hutson, SM | 1 |
| Cooper, ME; Komers, R | 1 |
| Cao, Z; Cooper, ME; Hulthén, UL; Johnston, CI; Rumble, JR | 1 |
| Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S | 1 |
| Agell, N; Alvarez, B; Argilś, JM; Busquets, S; Lpez-Soriano, FJ; Rodríguez, T | 1 |
| Farrell, PA; Fedele, MJ; Vary, TC | 1 |
| Cooper, ME; Gibbs, NJ; Kelly, DJ; Skinner, SL; Wilkinson-Berka, JL | 1 |
| Allen, TJ; Bertram, JF; Cooper, ME; Gilbert, RE; Hulthen, UL; Kelly, DJ; Mifsud, SA; Wilkinson-Berka, JL | 1 |
| Shimoni, Y | 1 |
| Cooper, ME; Cox, AJ; Gilbert, RE; Kelly, DJ; Tolcos, M; Wilkinson-Berka, JL | 1 |
| Lin, S; Wen, H | 1 |
| Dagistanli, FK; Erek, E; Kalender, B; Oztürk, M; Tunçdemir, M; Uysal, O; Yegenaga, I | 1 |
| Grizard, J; Maciejewska, M; Pion, R; Prugnaud, J | 1 |
| Ingebretsen, WR; Sampson, L; Wagle, SR | 1 |
| Castorina-Ziparo, S; Edelstein, E; Fischer, JE; James, JH; Ziparo, V | 1 |
| Buse, MG; Frayser, R | 1 |
| Duff, DA; Snell, K | 1 |
| Naito, H; Nam, TJ; Noguchi, T | 1 |
| Barac-Nieto, M; Liu, SM; Lui, SM; Spitzer, A | 1 |
| Debnam, ES; Ebrahim, HY | 1 |
| Aftring, RP; Buse, MG; Manos, PN | 1 |
| Chackerian, MJ; Leon, HA | 1 |
1 review(s) available for valine and Alloxan Diabetes
| Article | Year |
|---|---|
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.
Topics: Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Glycation End Products, Advanced; Tetrazoles; Valine; Valsartan | 2004 |
77 other study(ies) available for valine and Alloxan Diabetes
| Article | Year |
|---|---|
Urinary Metabolomics Study on the Protective Role of Cocoa in Zucker Diabetic Rats via
Topics: Amino Acids, Branched-Chain; Animals; Blood Glucose; Cacao; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonoids; Glycated Hemoglobin; Isoleucine; Ketone Bodies; Leucine; Male; Metabolomics; Proton Magnetic Resonance Spectroscopy; Rats; Rats, Zucker; Valine | 2022 |
A Hypothalamic Leptin-Glutamate Interaction in the Regulation of Sympathetic Nerve Activity.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Excitatory Amino Acid Antagonists; Gene Knockdown Techniques; Glutamic Acid; Heart Rate; Hypothalamus; Kidney; Leptin; Male; Microinjections; Rats; Rats, Sprague-Dawley; Receptors, Leptin; Receptors, N-Methyl-D-Aspartate; RNA, Small Interfering; Sympathetic Nervous System; Valine | 2017 |
Urinary Excretion of 2-Oxo Acids Is Greater in Rats with Streptozotocin-Induced Diabetes.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Energy Intake; Energy Metabolism; Hemiterpenes; Isoleucine; Keto Acids; Male; Rats, Wistar; Renal Elimination; Streptozocin; Valine; Weight Gain | 2018 |
Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Apoptosis; Arginine; Diabetes Mellitus, Experimental; Diet, High-Fat; Drug Combinations; eIF-2 Kinase; Endoplasmic Reticulum Stress; Glucose; Glucose Transporter Type 4; Glutathione Peroxidase; Glycogen; Heat-Shock Proteins; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, Leptin; Tetrazoles; Transcription Factor CHOP; Valine; Valsartan | 2013 |
Male hypogonadism induced by high fat diet and low dose streptozotocin is mediated by activated endoplasmic reticulum stress and IκBβ and attenuated by argirein and valsartan.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Arginine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Combinations; Endoplasmic Reticulum Stress; Hypogonadism; I-kappa B Proteins; Male; Rats; Rats, Sprague-Dawley; Sexual Behavior, Animal; Streptozocin; Tetrazoles; Valine; Valsartan | 2013 |
Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Gene Expression Regulation, Enzymologic; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2013 |
3-nitrotyrosine, a biomarker for cardiomyocyte apoptosis induced by diabetic cardiomyopathy in a rat model.
Topics: Animals; Apoptosis; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Tetrazoles; Tyrosine; Valine; Valsartan | 2013 |
Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Diabetes Mellitus, Experimental; Kidney; Male; Membrane Proteins; Mycophenolic Acid; Podocytes; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan; WT1 Proteins | 2013 |
Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Topics: Adamantane; Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Fatty Liver; Homeodomain Proteins; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Nitriles; Phlorhizin; Pyrrolidines; Tetrazoles; Trans-Activators; Valine; Valsartan; Vildagliptin | 2013 |
Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Extracellular Matrix Proteins; Fibronectins; Gene Expression Regulation; Inflammation; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Cortex; Kidney Glomerulus; Membrane Proteins; Mice; Oxidative Stress; Plasminogen Activator Inhibitor 1; Podocytes; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta1; Treatment Outcome; Valine; Valsartan; WT1 Proteins | 2014 |
Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Down-Regulation; Fumarates; Kallikreins; Kininogens; Kinins; Mice; Mice, Knockout; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Ultrasonography; Valine; Valsartan | 2013 |
Protective effects of aliskiren and valsartan in mice with diabetic nephropathy.
Topics: Albumins; Amides; Animals; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Fumarates; Inflammation; Lipid Metabolism; Male; Membrane Proteins; Mesangial Cells; Mice, Inbred DBA; Podocytes; Protective Agents; Proteinuria; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2014 |
Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.
Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Chromatin Immunoprecipitation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucose Tolerance Test; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Tetrazoles; Thromboplastin; Toll-Like Receptor 2; Toll-Like Receptor 4; Valine; Valsartan | 2014 |
Treatment effect of l-Norvaline on the sexual performance of male rats with streptozotocin induced diabetes.
Topics: Animals; Arginase; Blood Glucose; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Erectile Dysfunction; Hormones; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Sexual Behavior, Animal; Sildenafil Citrate; Sperm Count; Sperm Motility; Testis; Valine | 2016 |
[Effects of valsartan on the renal vascular endothelial growth factor and its receptor flk-1 of diabetic rats].
Topics: Animals; Antihypertensive Agents; Blotting, Western; Diabetes Mellitus, Experimental; Immunohistochemistry; Kidney; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2008 |
[Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Topics: Animals; Antihypertensive Agents; Apoptosis; Apoptosis Regulatory Proteins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Kidney; Male; Mycophenolic Acid; NF-kappa B; Random Allocation; Rats; Rats, Wistar; Tetrazoles; TNF-Related Apoptosis-Inducing Ligand; Treatment Outcome; Valine; Valsartan | 2008 |
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Kidney; Male; Microdialysis; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan | 2008 |
Ameliorative effect of Captopril and Valsartan on an animal model of diabetic cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Isoenzymes; L-Lactate Dehydrogenase; Male; Microscopy, Electron; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2008 |
[The effect of valsartan and fluvastatin on the connective tissue growth factor expression in experimental diabetic cardiomyopathy].
Topics: Animals; Cardiomyopathies; Connective Tissue; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Male; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2009 |
Effect of renin angiotensin system blockade on the islet microvessel density of diabetic rats and its relationship with islet function.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Microvessels; Perindopril; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2009 |
Effects of renin-angiotensin system blockade on islet function in diabetic rats.
Topics: Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Glucose Tolerance Test; In Situ Nick-End Labeling; Islets of Langerhans; Male; Nitric Oxide Synthase Type II; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2010 |
Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Calpain; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Kidney Glomerulus; Male; NF-kappa B; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Streptozocin; Tetrazoles; Transcription Factor RelA; Valine; Valsartan | 2010 |
Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Topics: Animals; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Hyperglycemia; Male; Mesangial Cells; Oligopeptides; Prorenin Receptor; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; RNA, Small Interfering; Signal Transduction; Tetrazoles; Transforming Growth Factor beta1; Up-Regulation; Valine; Valsartan | 2011 |
Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Endoplasmic Reticulum; Fluorescent Antibody Technique; Male; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Tetrazoles; Transcription Factor CHOP; Valine; Valsartan; Ventricular Remodeling | 2011 |
Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.
Topics: Administration, Oral; Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fumarates; Hemodynamics; Immunoblotting; Male; Mice; Mice, Inbred Strains; Myocardial Infarction; Myocardial Reperfusion Injury; Receptor, Angiotensin, Type 1; Renin; Tetrazoles; Valine; Valsartan | 2011 |
Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats.
Topics: Animals; Blood Glucose; Blotting, Western; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin-1; Gene Expression; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kidney; Male; Nephritis, Interstitial; Proteinuria; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Streptozocin; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Valine; Valsartan | 2012 |
Aquaporin changes during diabetic retinopathy in rats are accelerated by systemic hypertension and are linked to the renin-angiotensin system.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Aquaporins; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glial Fibrillary Acidic Protein; Hypertension; Metoprolol; Nerve Fibers; Neuroglia; Rats; Rats, Inbred WKY; Renin-Angiotensin System; Retina; Tetrazoles; Valine; Valsartan | 2012 |
Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Fatty Liver; Gene Expression Regulation; Hepatocytes; In Situ Nick-End Labeling; Liver Cirrhosis, Experimental; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2012 |
Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Imidazoles; Liver Cirrhosis; Losartan; Male; Microscopy, Electron; Rats; Tetrazoles; Valine; Valsartan | 2012 |
Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Glucagon; Glucose Transporter Type 1; Glycated Hemoglobin; Glycogen; Hypertension; Kidney; Male; Norepinephrine; Proteinuria; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2013 |
Diabetes onset influences hippocampal synaptic plasticity in streptozotocin-treated rats.
Topics: Age Factors; Age of Onset; Analysis of Variance; Animals; Animals, Newborn; Biophysics; Diabetes Mellitus, Experimental; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Neural Pathways; Neuronal Plasticity; Neurons; Patch-Clamp Techniques; Picrotoxin; Rats; Rats, Wistar; Reaction Time; Receptors, Glutamate; Streptozocin; Synapses; Valine | 2012 |
Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Diabetes Mellitus, Experimental; Fumarates; Heart; Humans; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Prorenin Receptor; Receptors, Cell Surface; Renin; Tetrazoles; Valine; Valsartan | 2013 |
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Hypertension; Kidney Glomerulus; Male; Membrane Proteins; Proteins; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Sclerosis; Systole; Tetrazoles; Valine; Valsartan; Verapamil | 2003 |
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Topics: Alanine; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Captopril; Cardiomegaly; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Enzyme Inhibitors; Hypertension; Hypertrophy; Male; Mesenteric Arteries; Neprilysin; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2003 |
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperglycemia; Liver; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nicorandil; Nifedipine; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; RNA, Messenger; Saralasin; Tetrazoles; Valine; Valsartan | 2003 |
The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats.
Topics: Albuminuria; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Space; Hypertension, Renal; Kidney; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2003 |
Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Fluid; Kidney; Losartan; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2004 |
[The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Mice; Random Allocation; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2004 |
Renoprotective effect of combining angiotensin II receptor blockers and statins in diabetic rats.
Topics: Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Kidney; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transcription Factor RelA; Valine; Valsartan | 2005 |
Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Extracellular Fluid; Kidney; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Thromboxane B2; Valine; Valsartan | 2005 |
Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor.
Topics: Adrenalectomy; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Cytochrome P-450 CYP11B2; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Insulin; Kidney; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger; Sodium Chloride; Steroid Hydroxylases; Tetrazoles; Tissue Distribution; Valine; Valsartan | 2005 |
[Effect of valsartan on Tribble 3 gene expression in rats with experimental diabetic cardiomyopathy].
Topics: Animals; Cardiomyopathy, Dilated; Diabetes Mellitus, Experimental; Gene Expression; Male; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2006 |
[Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Experimental; Fibrosis; Heart; Male; Myocardium; Random Allocation; Rats; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrazoles; Thrombospondin 1; Transforming Growth Factor beta; Valine; Valsartan | 2006 |
Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Topics: Adrenal Medulla; Adrenalectomy; Angiotensin II Type 1 Receptor Blockers; Animals; beta-Endorphin; Blood Glucose; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucose Transporter Type 4; Glutathione Peroxidase; Liver; Male; Mice; Mice, Knockout; Muscle, Skeletal; Rats; Rats, Wistar; Receptors, Opioid, mu; RNA, Messenger; Streptozocin; Tetrazoles; Tissue Culture Techniques; Valine; Valsartan | 2007 |
Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atenolol; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Female; Hypertension; Neuroglia; Photic Stimulation; Rats; Retina; Tetrazoles; Valine; Valsartan | 2007 |
Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Atenolol; Blood Pressure; Body Weight; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Female; Glycated Hemoglobin; Rats; Rats, Sprague-Dawley; Renin; Retinal Vessels; Tetrazoles; Valine; Valsartan | 2007 |
[Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blotting, Western; Cardiomyopathies; Cholesterol; Diabetes Mellitus, Experimental; Fasting; Insulin; Male; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Smad2 Protein; Smad3 Protein; Smad7 Protein; Tetrazoles; Transforming Growth Factor beta1; Triglycerides; Valine; Valsartan | 2007 |
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzamides; Blotting, Western; Cell Adhesion; Chemokine CCL2; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Imidazoles; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Retinitis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidines; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2007 |
Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus, Experimental; Hypertension; Male; Metoprolol; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin; Tetrazoles; Valine; Valsartan | 2007 |
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Imidazoles; Immunohistochemistry; Kidney Glomerulus; Kidney Tubules; NADPH Oxidases; Onium Compounds; Prorenin Receptor; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Up-Regulation; Valine; Valsartan | 2008 |
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus, Experimental; Extracellular Signal-Regulated MAP Kinases; Immunoblotting; Mice; Mice, Inbred C57BL; Neurons; Oncogene Protein v-akt; Phosphorylation; Receptor, Angiotensin, Type 1; Retina; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Synaptophysin; Telmisartan; Tetrazoles; Ubiquitination; Valine; Valsartan | 2008 |
Comparative study of the control of amylase biosynthesis in rat pancreas and parotid glands.
Topics: Amylases; Animals; Carbon Isotopes; Diabetes Mellitus, Experimental; Diet; DNA; Insulin; Male; Pancreas; Parotid Gland; Phosphorus; Rats; Valine | 1967 |
Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain.
Topics: Amino Acids; Amino Acids, Branched-Chain; Animals; Blood-Brain Barrier; Brain; Diabetes Mellitus, Experimental; Dietary Proteins; Insulin; Isoleucine; Leucine; Male; Phenylalanine; Rats; Rats, Inbred Strains; Tryptophan; Tyrosine; Valine | 1983 |
Effect of food intake on intestinal absorption and mucosal hydrolases in alloxan diabetic rats.
Topics: Alkaline Phosphatase; alpha-Glucosidases; Animals; Body Weight; Diabetes Mellitus, Experimental; Diet; Galactose; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Male; Rats; Sucrase; Valine | 1980 |
Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
Topics: Amino Acids, Branched-Chain; Animals; Diabetes Mellitus, Experimental; Diet; Hemiterpenes; Humans; Isoleucine; Keto Acids; Leucine; Male; Maple Syrup Urine Disease; Rats; Starvation; Valine | 1981 |
Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Hemodynamics; Kinins; Male; Ramipril; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles; Time Factors; Valine; Valsartan | 1995 |
Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Capillary Permeability; Cardiomegaly; Coloring Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Dihydropyridines; Evans Blue; Hypertension; Hypertrophy; Kidney; Male; Mesenteric Arteries; Ramipril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Serum Albumin; Tetrazoles; Valine; Valsartan | 1996 |
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 1997 |
Protein turnover in skeletal muscle of the diabetic rat: activation of ubiquitin-dependent proteolysis.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adipose Tissue; Animals; Body Weight; Diabetes Mellitus, Experimental; Female; Hydrolysis; Hyperglycemia; Insulin; Isoleucine; Kidney; Leucine; Liver; Liver Glycogen; Methylhistidines; Muscle Development; Muscle Proteins; Muscle, Skeletal; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ubiquitins; Valine | 1998 |
Selected Contribution: IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic rats.
Topics: Animals; Antibodies; Diabetes Mellitus, Experimental; Eating; Fasting; Insulin-Like Growth Factor I; Kinetics; Leucine; Male; Muscle Proteins; Muscle, Skeletal; Pancreatectomy; Phenylalanine; Rats; Rats, Sprague-Dawley; Reference Values; Valine | 2001 |
Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Heterozygote; Kidney; Perindopril; Rats; Renin; Tetrazoles; Valine; Valsartan | 2001 |
Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Basement Membrane; Blood Pressure; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Humans; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2001 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Apoptosis; Atrophy; Autoradiography; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epidermal Growth Factor; Female; Fibrosis; Gene Expression; In Situ Hybridization; In Situ Nick-End Labeling; Kidney Tubules; Nephritis, Interstitial; Perindopril; Rats; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2002 |
[Renal protective effect of valsartan in diabetic rats].
Topics: Animals; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Fibronectins; Kidney; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan | 1999 |
Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Female; Immunoenzyme Techniques; Immunohistochemistry; Kidney; Organ Size; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2002 |
[Influence of L-leucine overloading on the level of free amino acids in the diabetic rat].
Topics: Amino Acids; Animals; Corticosterone; Diabetes Mellitus, Experimental; Growth Disorders; Insulin; Insulin Secretion; Isoleucine; Leucine; Liver; Male; Muscles; Rats; Secretory Rate; Valine | 1976 |
Studies on gluconeogenesis, protein synthesis and cyclic AMP levels in isolated hepatocytes from alloxan diabetic rats.
Topics: Animals; Cyclic AMP; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Fructose; Glucagon; Gluconeogenesis; Histocytochemistry; Isoleucine; Lactates; Lipid Metabolism; Liver; Liver Glycogen; Male; Phenylalanine; Protein Biosynthesis; Rats; Theophylline; Vacuoles; Valine | 1975 |
Streptozotocin-induced diabetes in rats decreases brain tryptophan uptake after portacaval anastomosis.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Isoleucine; Leucine; Male; Phenylalanine; Portacaval Shunt, Surgical; Rats; Tryptophan; Tyrosine; Valine | 1979 |
Branched chain amino acid metabolism in the retina of diabetic rats.
Topics: Amino Acids; Animals; Diabetes Mellitus, Experimental; Glucose; Insulin; Isoleucine; Leucine; Male; Protein Biosynthesis; Rats; Retina; Valine | 1978 |
Alanine release by rat adipose tissue in vitro.
Topics: Adipose Tissue; Alanine; Animals; Diabetes Mellitus, Experimental; Glucose; Glutamates; Lactates; Leucine; Male; Rats; Starvation; Valine | 1977 |
Changes in the urinary excretion of acid-soluble peptides in rats injected with streptozotocin or dexamethasone: a trial to estimate the changes in the rate of whole-body protein degradation in those rats.
Topics: Adrenalectomy; Animals; Blood Glucose; Body Weight; Dexamethasone; Diabetes Mellitus, Experimental; Dietary Proteins; Leucine; Male; Nitrogen; Peptides; Proteins; Rats; Rats, Inbred Strains; Streptozocin; Valine | 1991 |
Renal protein synthesis in diabetes mellitus: effects of insulin and insulin-like growth factor I.
Topics: Animals; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Insulin; Insulin-Like Growth Factor I; Kidney Tubules, Proximal; Protein Biosynthesis; Proteins; Rats; RNA, Transfer, Val; Tritium; Valine | 1991 |
Autoradiographic localization of Na(+)-dependent L-valine uptake by the jejunum of streptozotocin-diabetic rats.
Topics: Animals; Autoradiography; Biological Transport, Active; Cell Movement; Diabetes Mellitus, Experimental; Jejunum; Male; Rats; Rats, Inbred Strains; Sodium; Valine | 1990 |
Catabolism of branched-chain amino acids by diaphragm muscles of fasted and diabetic rats.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Amination; Amino Acids, Branched-Chain; Animals; Diabetes Mellitus, Experimental; Diaphragm; Fasting; In Vitro Techniques; Keto Acids; Ketone Oxidoreductases; Leucine; Male; Multienzyme Complexes; Muscles; Oxidation-Reduction; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains; Transaminases; Valine | 1985 |
Nutritional and hormonal factors concerned with the regulation of liver protein synthesis during acute centrifugation stress.
Topics: Acceleration; Adrenalectomy; Animals; Blood Glucose; Carbon Isotopes; Cell-Free System; Centrifugation; Diabetes Mellitus, Experimental; Fasting; Hypophysectomy; In Vitro Techniques; Liver; Male; Microsomes; Protein Biosynthesis; Rats; Stress, Physiological; Valine | 1968 |
[The action of insulin on the biosynthesis of amylase and some other enzymes of rat pancreas].
Topics: Amino Acids; Amylases; Animals; Autoanalysis; Blood Glucose; Carbon Isotopes; Chymotrypsin; Depression, Chemical; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Enzyme Precursors; Humans; Insulin; Lipase; Male; Pancreas; Rats; Starch; Stimulation, Chemical; Valine | 1968 |